Navigation Links
ConjuGon receives $500,000 to battle bacteria

MADISONConjuGon, Inc. has received a $500,000 federal research grant, the company announced Tuesday.

ConjuGon was awarded a phase II small-business innovation research grant from the National Science Foundation to continue work on an antibacterial treatment. The funding complements the $1......

Full article >>> ="http://www.commerce.state.wi.us/">Wisconsin Department of Commerce.

Madison-based ConjuGon is developing therapeutics to combat antibiotic-resistant bacterial infections, a growing medical concern. Based on University of Wisconsin-Madison research, the company has developed technologies to eliminate pathogenic bacteria while reducing the bacterias ability to resist treatment.......

Full article >>>
'"/>

Source:wistechnology.com By Kristin V. Johnson 07/14/04


Related biology technology :

1. ConjuGon raises $3.3 million to fund clinical trials
2. ConjuGon gets $730K to treat infections
3. ConjuGon lands $1 million angel investment
4. ConjuGon to present at Sachs-Bloomberg Global Biotech Forum
5. ConjuGon Awarded $250,000
6. Medical College receives $377K to study brain disease
7. Lucigen receives $750K grant to boost biofuel yields
8. Medical College receives $1.4M cancer grant
9. Wisconsin biotech firm receives $107K NIH grant
10. InvivoSciences receives NIH grant for heart technology
11. Medical College receives $11 million grant to study high blood pressure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
Breaking Biology News(10 mins):